HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
AGIO
Agios Pharmaceuticals Inc
Healthcare Biotechnology · Massachusetts, USA · Reports in usd
Market Cap: $1.48B
Market Cap
$1.48B
Enterprise Val
$662.3M
P/E Ratio
-3.58
P/B Ratio
1.24
Trailing PEG (1Y)
-0.47
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$1.19B
Gross Margin90.59%
Profit Margin90.59%
Return on Equity-31.07%
Return on Assets-28.92%
Current Ratio11.46
Debt/Equity0.03
LT Debt/Equity0.02
Revenue Per Share0.34

Income Statement

Dec 31, 2025
Revenue$20.0M
Cost of Revenue$1.9M
Gross Profit$18.1M
R&D$88.1M
SG&A$51.6M
Operating Expenses$139.7M
Operating Income-$121.6M
Interest Expense$0.00
Tax Expense-$1.0M
Net Income-$108.0M
EPS (Basic)$-1.85
EPS (Diluted)$-1.85
EBIT-$109.1M
EBITDA-$104.6M
Consolidated Income-$108.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$89.1M
Accounts Receivable$10.6M
Inventory$32.9M
Current Assets$942.1M
LT Investments$310.0M
Property, Plant & Equipment$41.2M
Intangibles$0.00
Non-Current Assets$355.2M
Total Assets$1.30B
Accounts Payable$18.4M
Current Debt$18.4M
Current Liabilities$82.2M
LT Debt$21.8M
Non-Current Liabilities$21.9M
Total Liabilities$104.1M
Total Debt$40.2M
Retained Earnings-$561.7M
Shareholder Equity$1.19B
Shares Outstanding58,313,812

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$96.2M
Investing Cash Flow$90.1M
Financing Cash Flow$2.6M
CapEx-$1.1M
Free Cash Flow-$97.3M
Depreciation & Amort.$4.5M
Stock-Based Comp$14.1M
Acquisitions / Disposals$0.00
Investment Activity$91.2M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$2.6M
Dividends Paid$0.00
Net Change in Cash-$3.6M
Data cached · Meta live · Daily live · Statements live · TTL 24h